A Novel NR0B1 Gene Mutation Causes Different Phenotypes in Two Male Patients with Congenital Adrenal Hypoplasia

Abstract

X-linked congenital adrenal hypoplasia is characterised by the acute onset of primary adrenal insufficiency in infancy or early childhood and hypogonadotropic hypogonadism (HH) at puberty, arising from mutations of the nuclear receptor subfamily 0 group B member 1 (NR0B1) gene. This study investigated an extended family with two affected males (patient A: 23 years and patient B: 2 months old) and three carrier females. Sequencing analysis of the NR0B1 gene coding region from the family revealed a novel hemizygous deletion [c.604delT; p.(C202Afs*62)] in the two male patients. Furthermore, the patients’ respective mothers and their common grandmother had this heterozygous mutation, but it was not present in the Human Gene Mutation Database. The two male patients showed inconsistent clinical features at onset, particularly in early childhood; however, it is possible that the younger patient will eventually show a delay of puberty, feminisation, and nonspermatogenesis in adulthood, similar to that in the older patient. Identification of a novel NR0B1 mutation in this family is important for the diagnosis and genetic counselling of children with primary adrenal insufficiency and HH, and will be helpful for predicting long-term clinical symptoms.

Keywords

nuclear receptor subfamily 0 group B member 1 gene / hypogonadotropic hypogonadism / X-linked adrenal hypoplasia congenita

References

[1] MuscatelliF, StromTM, WalkerAP, et al.. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature, 1994, 372(6507): 672-676

[2] ChoiJH, ShinYL, KimGH, et al.. Identification of novel mutations of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenital. Horm Res, 2005, 63(4): 200-205

[3] RojekA, KrawczynskiMR, JamsheerA, et al.. X-linked adrenal hypoplasia congenita in a boy due to a novel deletion of the entire NROB1 (DAX1) and MAGEB1-4 genes. Int J Endocrinol, 2016, 2016: 5178953

[4] ChangGY, DongZY, WangW, et al.. The analysis of clinical manifestations and genetic mutations in Chinese boys with primary adrenal insufficiency. J Pediatr Endocrinol Metab, 2012, 25(3–4): 295-300

[5] Rodriguez EstévezA, Pérez-NanclaresG, Fernández-ToralJ, et al.. Clinical and molecular characterization of five Spanish kindreds with X-linked adrenal hypoplasia congenita: atypical findings and a novel mutation in NR0B1. J Pediatr Endocrinol Metab, 2015, 28(9–10): 1129-1137

[6] AchermannJC, MeeksJJ, JamesonJL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol, 2001, 185: 17-25

[7] BizzarriC, OliviniN, PedicelliS, et al.. Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single centre 10-year experience. Ital J Pediatr, 2016, 42(1): 73

[8] LiN, LiuR, ZhangH, et al.. Seven novel DAX1 mutations with loss of function identified in Chinese patients with congenital adrenal hypoplasia. J Clin Endocrinol Metab, 2010, 95(9): E104-111

[9] HabibyRL, BoeppleP, NachtigallL, et al.. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest, 1996, 98(4): 1055-1062

[10] FuY, NieM, XiaWB, et al.. Clinical features of 9 patients with X-linked adrenal hypoplasia congenital caused by DAX1/NR0B1 gene mutations. Zhonghua Yi Xue Za Zhi (Chinese), 2010, 90(30): 2119-2122

[11] BattistaMC, OtisM, CoteM, et al.. Extracellular matrix and hormones modulate DAX-1 localization in the human foetal adrenal gland. J Clin Endocrinol Metab, 2005, 90: 5426-5431

[12] RojekA, Obara-MoszynskaM, MaleckaE, et al.. NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding. J Appl Genet, 2013, 54(2): 225-230

[13] IyerAK, McCabeER. Molecular mechanisms of DAX1 action. Mol Genet Metab, 2004, 83(1–2): 60-73

[14] TamaiKT, MonacoL, AlastaloTP, et al.. Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol, 1996, 10(12): 1561-1569

[15] ZhengJJ, WuXY, NieM, et al.. Dysfunction of hypothalamic-pituitary-testicular axis in patients with adrenal hypoplasiacongenita due to DAX-1 gene mutation. Zhonghua Yi Xue Za Zhi (Chinese), 2016, 96(15): 1183-1187